Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic

The Coronavirus (COVID-19) pandemic and its associated health restrictions have harmed the population psychologically. We aimed to compare the post-traumatic stress disorder (PTSD) symptoms and Quality of Life (QoL) in older French patients with cancer to the younger ones. This longitudinal multicen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of geriatric oncology 2023-11, Vol.14 (8), p.101634-101634, Article 101634
Main Authors: Cherifi, Francois, Gernier, François, Jardin, Fabrice, Lefevre-Arbogast, Sophie, Bastien, Etienne, Lequesne, Justine, Rigal, Olivier, Quilan, Florian, Clarisse, Bénédicte, Grellard, Jean-Michel, Binarelli, Giulia, Fernette, Marie, Lange, Marie, Richard, Doriane, Morel, Adeline, Griffon, Bénédicte, Pepin, Louis-Ferdinand, Leconte, Alexandra, Faveyrial, Audrey, Leheurteur, Marianne, Beauplet, Bérengère, Joly, Florence
Format: Article
Language:English
Subjects:
Aged
Cognition
Communicable Disease Control
COVID-19 - epidemiology
Humans
Longitudinal Studies
Neoplasms
Neoplasms - therapy
Older adult
Pandemics
Post-traumatic stress disorder symptoms
Quality of life
Quality of Life - psychology
Sleep Initiation and Maintenance Disorders - epidemiology
Stress Disorders, Post-Traumatic - diagnosis
Stress Disorders, Post-Traumatic - epidemiology
Stress Disorders, Post-Traumatic - psychology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Coronavirus (COVID-19) pandemic and its associated health restrictions have harmed the population psychologically. We aimed to compare the post-traumatic stress disorder (PTSD) symptoms and Quality of Life (QoL) in older French patients with cancer to the younger ones. This longitudinal multicenter study named COVIPACT began in April 2020 during the first French lockdown and has included 579 outpatients receiving treatment for a solid or hematological malignancy. Data were collected every three months, namely at the first release period (M3), at the second lockdown (M6), at the second release period (M9), and finally at the last curfew period (M12) in France. Standardized validated self-questionnaires were used to assess PTSD symptoms (using the Event Scale–Revised self-questionnaire), insomnia (through the Insomnia Severity Index questionnaire), QoL (using the Functional Assessment of Cancer Therapy - General questionnaire), and cognitive complaints (through the Functional Assessment of Cancer Therapy – Cognition questionnaire). Student (or Wilcoxon) tests and Chi-squared tests were used for continuous or discrete variables, respectively. We conducted linear mixed model to study the change during follow-up. Out of 579 included patients, 157 (27%) were ≥ 70 years old at baseline, of whom 104 participated in the longitudinal study. At baseline, older patients reported fewer PTSD symptoms (17% versus 23%, p = .06), insomnia (17% versus 27%, p = .02), and cognitive complaint (3% versus 16%, p 
ISSN:1879-4068
1879-4076
DOI:10.1016/j.jgo.2023.101634